In these claims data, the record of a test that may guide treatment decisions would be present, but the results of such a test would not be available; for example, in NSCLC, where EGFR tests are regularly performed in order to inform decisions to use EGFR-targeted drugs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.